XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 69 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,970,000 | -39.8% | 3,661,237 | 0.0% | 0.44% | -21.1% |
| Q2 2021 | $14,901,000 | -3.3% | 3,661,237 | +7.1% | 0.56% | -5.9% |
| Q1 2021 | $15,416,000 | -24.9% | 3,418,200 | -18.1% | 0.59% | -54.8% |
| Q4 2020 | $20,528,000 | -17.0% | 4,172,459 | 0.0% | 1.31% | -35.0% |
| Q3 2020 | $24,743,000 | +122.9% | 4,172,459 | 0.0% | 2.02% | +81.1% |
| Q2 2020 | $11,099,000 | +76.1% | 4,172,459 | +29.1% | 1.12% | +44.4% |
| Q1 2020 | $6,303,000 | – | 3,232,459 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,000,641 | $29,496,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,308,666 | $22,694,000 | 0.92% |
| ArrowMark Colorado Holdings LLC | 1,656,422 | $16,283,000 | 0.16% |
| IHT Wealth Management, LLC | 57,028 | $561,000 | 0.08% |
| MOORE CAPITAL MANAGEMENT, LP | 50,000 | $492,000 | 0.02% |
| Engineers Gate Manager LP | 20,264 | $199,000 | 0.01% |
| FEDERATED HERMES, INC. | 300,000 | $2,949,000 | 0.01% |
| FMR LLC | 4,048,102 | $39,793,000 | 0.01% |
| Invesco Ltd. | 1,000,000 | $9,830,000 | 0.00% |
| MetLife Investment Management, LLC | 14,041 | $138,023 | 0.00% |